Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Paul Sorajja1, Robert Fraser2, Robert Steffen2
1Center for Valve and Structural Heart Disease, Minneapolis Heart Institute at Abbott Northwestern Hospital, 920 East, 28th Street, Minneapolis, MN 55417, USA; Valve Science Center, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, 800 East 28th Street, Minneapolis, MN 55401, USA; Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, 920 East, 28th Street, Minneapolis, MN 55417, USA.
Alcohol septal ablation offers clinical improvement for hypertrophic cardiomyopathy patients. Experienced operators and multidisciplinary teams ensure outcomes comparable to surgical myectomy for long-term patient care.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Alcohol septal ablation is an established therapy for specific hypertrophic cardiomyopathy (HCM) patients.
- The procedure aims to improve symptoms and functional capacity in individuals with obstructive HCM.
- Longitudinal care and patient selection are critical for successful outcomes.
Purpose of the Study:
- To highlight the established role and efficacy of alcohol septal ablation in managing hypertrophic cardiomyopathy.
- To emphasize the importance of experienced operators and multidisciplinary teams in achieving optimal results.
- To compare the outcomes of alcohol septal ablation with surgical myectomy.
Main Methods:
- This section is not detailed in the provided abstract.
- Focus is on the clinical application and outcomes of alcohol septal ablation.
- Patient selection criteria and procedural considerations are implicitly discussed.
Main Results:
- Alcohol septal ablation leads to clinical improvement in symptoms and functional capacity for selected HCM patients.
- Outcomes of alcohol septal ablation are comparable to those of surgical myectomy in many patients.
- Successful application requires careful patient selection and experienced proceduralists.
Conclusions:
- Alcohol septal ablation is a viable and effective treatment option for selected patients with hypertrophic cardiomyopathy.
- Optimizing outcomes necessitates experienced operators and a multidisciplinary team approach.
- The procedure offers a valuable alternative to surgical myectomy for long-term patient management.
More Related Videos
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Stenosis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
